Changing mizoribine administration from three divided doses to one single dose induced remission of relapsed membranous nephropathy.
Nishioka
Yoshiaki
Y
Horita
Yoshio
Y
Tadokoro
Masato
M
Taura
Koichi
K
Suyama
Naofumi
N
Miyazaki
Masanobu
M
Harada
Takashi
T
Kohno
Shigeru
S
D000368:Aged; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D015433:Glomerulonephritis, Membranous / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use; D011239:Prednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D011507:Proteinuria / Q000209:etiology; D012008:Recurrence; D012074:Remission Induction; D012263:Ribonucleosides / Q000008:administration & dosage* / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use
D007166:Immunosuppressive Agents; D012263:Ribonucleosides; C010052:mizoribine; D011239:Prednisolone